发布求助
文献互助 智能选刊 最新文献

Medical Letter on Drugs and Therapeutics最新文献

筛选
英文 中文
Belzutifan (Welireg) for advanced renal cell carcinoma. 贝珠替凡（Welireg）治疗晚期肾细胞癌。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701g
{"title":"Belzutifan (Welireg) for advanced renal cell carcinoma.","authors":"","doi":"10.58347/tml.2024.1701g","DOIUrl":"https://doi.org/10.58347/tml.2024.1701g","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1701","pages":"e75-e76"},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic prophylaxis for dental procedures. 牙科手术的抗生素预防。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701e
{"title":"Antibiotic prophylaxis for dental procedures.","authors":"","doi":"10.58347/tml.2024.1701e","DOIUrl":"10.58347/tml.2024.1701e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1701","pages":"71-72"},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140872738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resmetirom (Rezdiffra) for metabolic dysfunction-associated steatohepatitis. Resmetirom（Rezdiffra）治疗代谢功能障碍相关性脂肪性肝炎。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701a
{"title":"Resmetirom (Rezdiffra) for metabolic dysfunction-associated steatohepatitis.","authors":"","doi":"10.58347/tml.2024.1701a","DOIUrl":"10.58347/tml.2024.1701a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1701","pages":"65-66"},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cabtreo: A three-drug gel for acne. Cabtreo：治疗痤疮的三药凝胶
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-15 DOI: 10.58347/tml.2024.1700b
{"title":"Cabtreo: A three-drug gel for acne.","authors":"","doi":"10.58347/tml.2024.1700b","DOIUrl":"https://doi.org/10.58347/tml.2024.1700b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1700","pages":"59-60"},"PeriodicalIF":1.9,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Roflumilast foam (Zoryve) for seborrheic dermatitis. 治疗脂溢性皮炎的罗氟司特泡沫剂（Zoryve）。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-15 DOI: 10.58347/tml.2024.1700a
{"title":"Roflumilast foam (Zoryve) for seborrheic dermatitis.","authors":"","doi":"10.58347/tml.2024.1700a","DOIUrl":"https://doi.org/10.58347/tml.2024.1700a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1700","pages":"57-59"},"PeriodicalIF":1.9,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140872023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zilucoplan (Zilbrysq) for myasthenia gravis. 治疗重症肌无力的 Zilucoplan（Zilbrysq）。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-15 DOI: 10.58347/tml.2024.1700c
{"title":"Zilucoplan (Zilbrysq) for myasthenia gravis.","authors":"","doi":"10.58347/tml.2024.1700c","DOIUrl":"https://doi.org/10.58347/tml.2024.1700c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1700","pages":"60-62"},"PeriodicalIF":1.9,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140854445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Donislecel (Lantidra) for type 1 diabetes. 治疗 1 型糖尿病的 Donislecel（Lantidra）。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-15 DOI: 10.58347/tml.2024.1700d
{"title":"Donislecel (Lantidra) for type 1 diabetes.","authors":"","doi":"10.58347/tml.2024.1700d","DOIUrl":"https://doi.org/10.58347/tml.2024.1700d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1700","pages":"63-64"},"PeriodicalIF":1.9,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drugs for bipolar disorder. 治疗躁郁症的药物。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-01 DOI: 10.58347/tml.2024.1699a
{"title":"Drugs for bipolar disorder.","authors":"","doi":"10.58347/tml.2024.1699a","DOIUrl":"https://doi.org/10.58347/tml.2024.1699a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1699","pages":"49-54"},"PeriodicalIF":1.9,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140872147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addendum: Bupropion safety in pregnancy. 增编：妊娠期服用安非他酮的安全性。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-01 DOI: 10.58347/tml.2024.1699c
{"title":"Addendum: Bupropion safety in pregnancy.","authors":"","doi":"10.58347/tml.2024.1699c","DOIUrl":"https://doi.org/10.58347/tml.2024.1699c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1699","pages":"56"},"PeriodicalIF":1.9,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140860507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Omalizumab (Xolair) for food allergy. 治疗食物过敏的奥马珠单抗（Xolair）。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-04-01 DOI: 10.58347/tml.2024.1699b
{"title":"Omalizumab (Xolair) for food allergy.","authors":"","doi":"10.58347/tml.2024.1699b","DOIUrl":"https://doi.org/10.58347/tml.2024.1699b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1699","pages":"54-56"},"PeriodicalIF":1.9,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信